Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia.
about
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.
P2860
Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Neuroprotective Effects of Poly
@nl
Neuroprotective Effects of Pol ...... n Transient Cerebral Ischemia.
@en
type
label
Neuroprotective Effects of Poly
@nl
Neuroprotective Effects of Pol ...... n Transient Cerebral Ischemia.
@en
prefLabel
Neuroprotective Effects of Poly
@nl
Neuroprotective Effects of Pol ...... n Transient Cerebral Ischemia.
@en
P2093
P2860
P1476
Neuroprotective Effects of Pol ...... n Transient Cerebral Ischemia.
@en
P2093
Lingjing Jin
P2860
P2888
P304
P356
10.1007/S11064-016-1864-6
P577
2016-02-11T00:00:00Z